We want to keep you up to date with developments in the IP world and let you know what we are up to at Mewburn Ellis.


AstraZeneca cancer drug approved by US FDA

16 Jan 2018

The U.S. Food and Drug Administration has approved the expanded use of AstraZeneca Plc’s cancer drug Lynparza. The new approval is for use in patients with metastatic breast cancer whose disease is associated with a mutation of the BRCA gene.

FICPI Visit to the USPTO

16 Jan 2018

Partner Robert Watson will be visiting the United States Patent and Trademark Office (USPTO) on Monday 22 January 2018, as part of a FICPI delegation.

Global Intellectual Property Convention

12 Jan 2018

Rachel Oxley will be attending the Global Intellectual Property Convention in Bangalore, India from 23-25 January.

AUTM 2018 Annual Meeting

12 Jan 2018

Sam Bailey and Sean Jauss will be attending the AUTM 2018 Annual Meeting in Phoenix, Arizona from 18-21 February.

Mewburn Ellis strengthens European trade mark practice with partner hire in Munich office

10 Jan 2018

We are delighted to welcome Dydra Donath to the firm and to the partnership. Dydra, a highly experienced German national trade mark attorney with a doctorate in law joins our Munich Office. She will be responsible for driving forward not only our German trade mark practice, but further developing our well-established EU trade mark practice.

SomaLogic closes $200m financing round

09 Jan 2018

Our client SomaLogic has closed a $200million financing round led by Chinese healthcare firm iCarbonX. Nan Fung Life Sciences and Madryn Asset Management also invested in the round.

Southampton Law School Careers Programme 2018

08 Jan 2018

Associate Rebecca Anderson-Smith will be giving a talk on “A Career as a Trade Mark Attorney” to students at Southampton University on 18 January.

Professor Larry Gold named 2017 National Academy of Inventors Fellow

03 Jan 2018

Congratulations to Professor Larry Gold who has been named as a fellow of the National Academy of Inventors (NAI).

MIA International Energy Efficient Motorsport Conference

03 Jan 2018

Partners Stephen Carter and Simon Parry will be attending the MIA International Energy Efficient Motorsport Conference which takes place on 10 January at the NEC in Birmingham.

Life as a Trainee Patent Attorney: Sean Constable

28 Dec 2017

Sean Constable, trainee patent attorney in our life sciences patent team, joined Mewburn Ellis as part of our Graduate Training Programme in 2014. In this article he gives us an outline of what working as a trainee patent attorney at Mewburn Ellis is like.

Tessa Therapeutics completes USD 80 million funding round

21 Dec 2017

Congratulations to our client Tessa Therapeutics who have announced the successful completion of a USD 80 million funding round led by Temasek, an investment company headquartered in Singapore.

EPO clarifies law relating to disclosed and undisclosed disclaimers

20 Dec 2017

The Enlarged Board of Appeal has just handed down its decision G1/16 on disclaimers.  The decision untangles some of the confusion that has surrounded the allowability of disclaimers in recent years, and when they may or may not be considered as “added matter”.

Hitachi and Mitsubishi Agree to Integrate Particle Therapy System Business

20 Dec 2017

Hitachi, Ltd and Mitsubishi Electric Corporation have announced that they have signed an agreement to transfer Mitsubishi Electric’s particle therapy system business to Hitachi, and integrate it to one entity.

Autoliv receive award for future urban car safety from FCA

20 Dec 2017

Our client Autoliv has received a prestigious innovation award from Fiat Chrysler Automobiles (FCA) for their work on FCA’s future urban car safety project.

Proud Sponsors of the IET Innovation Awards

19 Dec 2017

This year we were proud sponsors of the Emerging Technologies category at the Institution of Engineering and Technology (IET) Innovation Awards.